SCHEMBL570625

SCHEMBL570625

CC(=O)S(C)(=O)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphine SCHEMBL28483754 0.96
SCHEMBL1387292 0.76
SCHEMBL28564048 0.76
SCHEMBL8706722 0.73
SCHEMBL11263204 0.73
SCHEMBL124000 0.73
SCHEMBL10404102 0.73 KDM4E (0.42)
SCHEMBL338422 0.73
SCHEMBL3584170 0.73
Acetone SCHEMBL2586373 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118136828-A Synergistic regulation and control method for cathode and anode ion states on surface of high nickel oxide cathode 北京科技大学 2024-06-04 CN claimed
EP-2683723-A1 SPIROCYCLIC ISOXAZOLINE DERIVATIVES AS ANTIPARASITIC AGENTS Zoetis LLC (US) 2014-01-15 EP claimed
WO-2012120399-A1 SPIROCYCLIC ISOXAZOLINE DERIVATIVES AS ANTIPARASITIC AGENTS PFIZER INC. (US) 2012-09-13 WO claimed
US-20260139039-A1 ANTIBODY, RELATED USE, PHARMACEUTICAL COMPOSITION INCLUDING METHOD FOR DIAGNOSING FUNGAL INFECTIONS, FUNGAL INFECTION DIAGNOSIS KIT AND METHOD FOR TREATING FUNGAL INFECTIONS FUND OSWALDO CRUZ (BR) 2026-05-21 US disclosed
US-20240299518-A1 METHOD FOR THE TREATMENT OF PATIENTS WITH CARCINOMAS CENTRO DE INMUNOLOGIA MOLECULAR (CU) 2024-09-12 US disclosed
CN-118515591-A Preparation method of allyl deuterated methyl sulfone compound 温州医科大学 2024-08-20 CN disclosed
US-20240262897-A1 ANTIBODY, RELATED USE, PHARMACEUTICAL COMPOSITION INCLUDING METHOD FOR DIAGNOSING FUNGAL INFECTIONS, FUNGAL INFECTION DIAGNOSIS KIT AND METHOD FOR TREATING FUNGAL INFECTIONS FUNDAÇÃO OSWALDO CRUZ (BR) 2024-08-08 US disclosed
US-12019073-B2 Method for the treatment of patients with carcinomas CENTRO DE INMUNOLOGIA MOLECULAR (CU) 2024-06-25 US disclosed
CN-118136828-A Synergistic regulation and control method for cathode and anode ion states on surface of high nickel oxide cathode 北京科技大学 2024-06-04 CN disclosed
CN-116600817-A Conjugated oligonucleotides for tissue-specific delivery 马萨诸塞大学 2023-08-15 CN disclosed
WO-2023116951-A1 FUSION PROTEINS COMPOSED OF AN ANTIBODY AND A MUTEIN CENTRO DE INMUNOLOGIA MOLECULAR (CU) 2023-06-29 WO disclosed
US-20070051922-A1 Polymer light-emitting material and polymer light-emitting device SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-03-08 US disclosed
US-20070051922-A1 Polymer light-emitting material and polymer light-emitting device SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-03-08 US disclosed
US-7138415-B2 Indolamid derivatives which possess glycogenphosphorylase inhibitory activity ASTRAZENECA AB (SE) 2006-11-21 US disclosed
US-20050107362-A1 Indolamid derivatives which possess glycogenphosphorylase inhibitory activity ASTRA ZENECA AB (SE) 2005-05-19 US disclosed
EP-1483240-A1 INDOLAMID DERIVATIVES WHICH POSSESS GLYCOGEN PHOSPHORYLASE INHIBITORY ACTIVITY AstraZeneca AB (SE) 2004-12-08 EP disclosed
WO-2003074484-A1 INDOLAMID DERIVATIVES WHICH POSSESS GLYCOGENPHOSPHORYLASE INHIBITORY ACTIVITY ASTRAZENECA AB (SE) 2003-09-12 WO disclosed
EP-0144087-B2 Heat-developable color light-sensitive material KONISHIROKU PHOTO IND (JP) 1995-05-24 EP disclosed
EP-0144087-B1 HEAT-DEVELOPABLE COLOR LIGHT-SENSITIVE MATERIAL KONICA CORPORATION (JP) 1990-04-18 EP disclosed
US-4355184-A BY REACTING AN ALDEHYDE WITH AN ALKALI METAL SALT OF ACETOACETIC NIPPON SODA COMPANY LIMITED (JP) 1982-10-19 US disclosed